Ebola vaccine to start clinical trials in early 2015

919

04 September 2014 15:43

Scientists will fast-track tests on another Ebola vaccine, this time from Johnson & Johnson JNJ.N, in another sign that the world's worst outbreak of the virus is mobilizing research into the deadly disease.

J&J said on Thursday that clinical trials of its new vaccine, which includes technology from Danish biotech firm Bavarian Nordic BAVA.CO, would commence in early 2015.

The move follows a decision to begin initial human testing of a GlaxoSmithKline GSK.L vaccine this month and plans to test one developed by Canadian government scientists, which has been licensed to NewLink Genetics NLNK.O, in the autumn.